BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25385075)

  • 1. Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients.
    Shibayama Y; Imafuku S
    J Dermatol; 2014 Dec; 41(12):1102-5. PubMed ID: 25385075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.
    Madani S; Marwaha S; Dusendang JR; Alexeeff S; Pham N; Chen EH; Han S; Herrinton LJ
    JAMA Dermatol; 2021 May; 157(5):559-565. PubMed ID: 33760003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
    Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
    Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
    Leiter U; Heppt MV; Steeb T; Alter M; Amaral T; Bauer A; Bechara FG; Becker JC; Breitbart EW; Breuninger H; Diepgen T; Dirschka T; Eigentler T; ElGammal AKS; Felcht M; Flaig MJ; Follmann M; Fritz K; Grabbe S; Greinert R; Gutzmer R; Hauschild A; Hillen U; Ihrler S; John SM; Kofler L; Koelbl O; Krause-Bergmann A; Kraywinkel K; Krohn S; Langer T; Loquai C; Löser CR; Mohr P; Nashan D; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Voelter-Mahlknecht S; Vordermark D; Weichenthal M; Welzel J; Wermker K; Wiegand S; Garbe C; Berking C
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1422-1433. PubMed ID: 37840404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
    Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
    JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
    Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM
    Arch Dermatol Res; 2022 Apr; 314(3):257-266. PubMed ID: 33813600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines.
    Christensen RE; Elston DM; Worley B; Dirr MA; Anvery N; Kang BY; Bahrami S; Brodell RT; Cerroni L; Elston C; Ferringer T; Hurley MY; Garton K; Lee JSS; Liu Y; Maize JC; McNiff JM; Rapini RP; Sangueza OP; Shea CR; Zhou C; Alam M
    J Am Acad Dermatol; 2023 Jun; 88(6):1317-1325. PubMed ID: 36841336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease.
    Leiter U; Heppt MV; Steeb T; Amaral T; Bauer A; Becker JC; Breitbart E; Breuninger H; Diepgen T; Dirschka T; Eigentler T; Flaig M; Follmann M; Fritz K; Greinert R; Gutzmer R; Hillen U; Ihrler S; John SM; Kölbl O; Kraywinkel K; Löser C; Nashan D; Noor S; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Welzel J; Wermker K; Garbe C; Berking C
    J Dtsch Dermatol Ges; 2020 Apr; 18(4):400-413. PubMed ID: 32247292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
    Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
    In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
    Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
    Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying risk factors for skin cancer development.
    Оshyvalova ОО
    Wiad Lek; 2017; 70(3 pt 1):503-507. PubMed ID: 28711897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.
    Zou DD; Sun YZ; Li XJ; Wu WJ; Xu D; He YT; Qi J; Tu Y; Tang Y; Tu YH; Wang XL; Li X; Lu FY; Huang L; Long H; He L; Li X
    Elife; 2023 Dec; 12():. PubMed ID: 38099574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.
    Zhang L; Qin H; Wu Z; Chen W; Zhang G
    Int J Dermatol; 2018 Oct; 57(10):1208-1217. PubMed ID: 30105812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
    Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
    Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
    Mohney L; Singh R; Grada A; Feldman S
    J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
    Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
    Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasibility study of microwave therapy for precancerous actinic keratosis.
    Jackson DN; Hogarth FJ; Sutherland D; Holmes EM; Donnan PT; Proby CM
    Br J Dermatol; 2020 Aug; 183(2):222-230. PubMed ID: 32030723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.
    Zalaudek I; Giacomel J; Schmid K; Bondino S; Rosendahl C; Cavicchini S; Tourlaki A; Gasparini S; Bourne P; Keir J; Kittler H; Eibenschutz L; Catricalà C; Argenziano G
    J Am Acad Dermatol; 2012 Apr; 66(4):589-97. PubMed ID: 21839538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.
    Lambert SR; Mladkova N; Gulati A; Hamoudi R; Purdie K; Cerio R; Leigh I; Proby C; Harwood CA
    Br J Cancer; 2014 Jan; 110(2):520-9. PubMed ID: 24335922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.